The best way to protect yourself and your family is to be vaccinated.
The company had a good first half and delivered record results.
Adjusted net income was $84.6 million or $3.62 per diluted share.
Both adjusted net income and adjusted earnings per share were up 35% versus the first half of 2020, which was negatively impacted by the Millsdale plant outage.
We delivered our best second quarter and had $42.2 million adjusted net income.
Surfactant operating income was down 5%, largely due to higher North American supply chain cost, driven by inflationary pressures and planned higher maintenance cost.
Let's just start with the Slide four to recap the quarter.
This project is the primary driver of our 2021 capital expenditure forecast of $150 million to $170 million and will carry over to 2022 as well.
